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Abstract: Neurodegeneration is the progressive loss of structure or function of neurons. Amyloid beta oligomers and aggregates have
been linked to neurodegeneration. While previous studies have suggested that dietary α-tocopherol intake can prevent amyloid beta
aggregation and protect the brain against neurotoxicity, other research, however, indicated that tocotrienol forms might be used as an
alternate agent against this kind of degeneration. In the presented research, we compared the in vitro protective effects of α-tocopherol
and α-tocotrienol. In this context, we formed an in vitro neurodegeneration model with primary isolated neurons and measured
α-tocopherol’s and α-tocotrienol’s protective effects. As a result, α-tocopherol and α-tocotrienol prevent the degeneration of neurons.
Moreover, α-tocopherol and α-tocotrienol regulated the neuron’s calcium channels mechanism by decreasing the expression of the
calcium channel alpha 1C subunit. We also observed that the amount of amyloid beta accumulation in the extracellular matrix decreased
with the application of these isoforms. In specific time points, α-tocopherol and α-tocotrienol differ in terms of protective effects. In
conclusion, it could be interpreted that, in more extended periods, α-tocotrienol could be a significant protective agent against amyloid
beta-induced neurodegeneration, and it can be used as an alternative to other protective agents, especially α-tocopherol.
Key words: Amyloid beta, Neurodegeneration, A-tocopherol, A-tocotrienol

1. Introduction
Neurodegeneration means the deterioration of neurons
for several reasons. It may occur due to various causes,
including the accumulation of protein aggregates such
as amyloid beta (Aβ) or tau, oxidative stress, and genetic
mutations (Hoeijmakers, 2009; Chang et al., 2018).
Pathologies of neurodegenerative diseases like Alzheimer’s
are generally characterized by the accumulation of
insoluble extracellular aggregates such as Aβ aggregates
in specific brain regions (Goedert, 2007). Aβ is a protein
fragment caused by the wrong process of a protein called
amyloid precursor protein (APP). Different Aβ forms take
names such as Aβ40 or Aβ42 based on the number of
amino acids they contain. Forms such as Aβ42 are much
more toxic than other forms of Aβ for the brain (Chen et
al., 2017; Rudajev and Novotny, 2020). Previous studies
show that Aβ disturbs cell membrane functions, increases
protein oxidation, creates oxidative stress, and harms the
mechanisms that regulate calcium channel influx in the
neuronal cells (Huang et al., 1999, Sciacca et al., 2018). Aβ
oligomers cause mitochondrial dysfunction in neurons
and induce oxidative stress, resulting in a large calcium
influx and increased neuronal toxicity (Canevari et al.,

2004). Studies show that lipophilic antioxidants such as
vitamin E could be used against neurogenerative disorders
like Alzheimer’s (Chang et al., 2018).
Vitamin E, an essential element for nutrition, is
produced only by photosynthetic organisms. It affects
many specific biological functions such as gene expression,
certain signaling pathways, and cell proliferation. It also
shows protective and curative effects against oxidative
stress and acts like an antioxidant in the body (Grimm et
al., 2005; Sen et al., 2006; Gugliandolo et al., 2019). There
are eight isoforms of vitamin E, four tocopherols, and
four tocotrienols. A-tocotrienol (A-T3) and α-tocopherol
(A-T) are abundant in many herbal products consumed,
especially vegetable oils (Sen et al., 2006; Ulatowski and
Manor, 2015). Vitamin E shows its neuroprotective effects
by preventing cell death resulting from Aβ-induced
protein oxidation and accumulation of reactive oxygen
species (ROS) (Yatin et al., 2000). Another study also
showed that vitamin E could induce the nonamyloidogenic
pathway of APP and modulate the autophagic flux in the
brain (Gugliandolo et al., 2019). Apart from protecting
cells against lipid peroxidation, vitamin E plays a critical
role in maintaining neurological health, and its deficiency
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may cause conditions such as cellular atrophy and
decreased branching of Purkinje neurons (Grimm et al.,
2005; Ulatowski et al., 2013; Ulatowski and Manor, 2015;
Gugliandolo et al., 2019). Some of the previous studies
suggested that although A-T and A-T3 show similar
effects at some levels against neurodegeneration, they
may have different effects in areas such as preventing Aβ
accumulation (Grimm et al., 2016; Ibrahim et al., 2021).
As stated in another study, A-T also provides a therapeutic
effect against oxidative damage in hippocampal cells
by being involved in calcium metabolism (Crouzin et
al., 2007). However, the effects of A-T and A-T3 on the
mechanisms regulating calcium channel flux induced by
Aβ have not been studied before, to our knowledge. Besides,
the effects of protective agents such as A-T and A-T3 on
the metabolism of Aβ-induced neurodegeneration are not
fully understood and continue to be studied (Chang et al.,
2018; Gugliandolo et al., 2019; Ibrahim et al., 2021; Yatin
et al., 2000). Considering this, we examined the protective
effects of A-T and A-T3 against Aβ-induced damage
within the scope of the study. To acquire reliable results, we
used cells obtained from primary neuron culture, which
show a high degree of similarity to human neurons, and
formed a neurodegeneration model. Then, we examined
A-T and A-T3 against Aβ-induced neurodegeneration and
compared them with each other in terms of cytotoxicity,
apoptosis, necrosis, Aβ aggregation value, and expression
of Beta-secretase 1 (BACE1) and Voltage-dependent
calcium channel alpha 1C subunit (Cacna1c) genes.
2. Materials and methods
2.1. Materials and chemicals
Amyloid β protein fragment 1-42 (CAS number: 10776142-2), α-tocopherol (CAS number: 10191-41-0), D-αtocotrienol (CAS number: 1721-51-3), cytosine β-Darabinofuranoside (CAS number: 147-94-4), L-glutamic
acid (CAS: number: 56-86-0), L-glutamine (CAS
number: 56-85-9), penicillin-streptomycin, (P/S) (CAS
number: 3810-74-0), Congo red (CAS Number: 573-580), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) (CAS Number: 298-93-1), methyl blue
(CAS number: 28983-56-4), neutral red solution (0.33%)
(CAS number: 553-24-2), TRI Reagent® (MDL number:
MFCD00213058), Triton™ X-100 (CAS number: 900293-1), acridine orange (AO) solution (CAS Number:
65-61-2), and propidium iodide (PI) solution (CAS
number: 25535-16-4) were obtained from Sigma-Aldrich
(Germany). DMEM - F12 W/ stable glutamine W/ 15 MM
Hepes (DMEM-F12) (Cat number: L0092-500), trypsinEDTA (0.25%), phenol red (Cat number: 25200056), and
Fetal Bovine Serum (FBS) (Cat number S1810-500) were
purchased from Biowest MO, USA. Neurobasal™ Medium
(Cat number: 21103049), B-27™ Plus supplement (50X)

(Cat number: A3582801), 2-mercaptoethanol (50 mM)
(Cat number: 31350010), and poly-D-lysine (PDL) (Cat
number: A3890401) were purchased from Thermo Fisher
Scientific, MA, USA. DAPI staining solution (ab228549),
goat anti-mouse IgG H&L (Texas Red ®) (ab6787), and
anti-MAP2 antibody [AP-20] (ab11268) were purchased
from Abcam, Cambridge, UK. All chemicals and solvents
were obtained as cell culture grade. Rattus norvegicus type
Wistar albino rats were purchased from the Laboratory
Animals Raising and Experimental Research Center
(GÜDAM), Ankara, Turkey.
2.2. Preparation of experimental animals and obtaining
embryos by surgical method
Embryos for use in primary neuron culture were obtained
by mating three female rats with a male rat. In this study,
we used a total of seven (six female and one male) rats
within the framework of the ethical permission provided
by the Hacettepe University Animal Experiments Local
Ethics Committee (decision number: 52338575-68).
After mating, vaginal plaque observation was performed
to determine the exact time of pregnancy, and rats with
vaginal plaque formation were considered starting day of
pregnancy. We applied daily care and controls to the rats
during their pregnancy. Pregnant rats were euthanized by
cervical dislocation on the 17th or 18th days. Subsequently,
the sacrificed rats were treated with 70% alcohol solution
to ensure disinfection.
The embryos extracted from pregnant rats by the
surgical method were transferred to 100 mm diameter
glass petri dishes filled with 10 mL of the ice-cold transfer
solution containing 1.5% (g/mL) sucrose and 0.6% (g/
mL) d-glucose. In order to keep cells alive by slowing their
metabolism, we performed all surgical procedures on the
embryos on ice. The brains were isolated under a dissecting
microscope (Zoom 2000, Leica Camera, USA). The cortex
regions of the isolated brains were then separated and
cleared from meninges. Mechanical dissection of the
cortices was carried out in a petri dish full of ice-cold
transfer solution using a sterile scalpel. Dissected cortex
pieces were then transferred to 15 mL tubes with 10 mL
of transfer solution to apply primary neuron isolation
methods.
2.3. Primary cortical neuron isolation and culture
For isolating neurons, we have followed the primary
neuronal isolation methods described previously (Yatin
et al., 2000). In this context, cortex pieces were washed
by centrifugation twice at 1000 rpm for 1 min. Then, the
pellet was separated and treated with 0.5 mL of 1X trypsin
and 4.5 mL of transfer solution in a 37 °C water bath to
break down the protein bonds in the tissues. At the end
of the incubation with trypsin, the pellet was washed two
times with 10 mL of DMEM/F12 medium. Afterward, the
supernatant was replaced with 5 mL of plating neurobasal
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medium (neurobasal medium, 2% B-27 ™ supplement
(50X), 1% 200 mM L-glutamine, 1% 100x P/S, 0.07%
10 mM β-mercaptoethanol, and 0.125 mM L-glutamic
acid). The cortices were mechanically broken down in the
medium by pipetting 3–5 times with a 10 mL pipette and
a glass Pasteur pipette. All tissues were broken down, and
the cells were distributed homogeneously in the medium;
dead cells and tissue pieces were left for 5 min to settle.
Then the supernatant was separated, and cells were seeded
at 104 cells/well in PDL-coated 96-well plate culture dishes.
Each well was subjected to the medium change in half on
day three with AraC Medium (Neurobasal Medium, 2%
B-27 ™ supplement (50X), 1% 200 mM L-glutamine, 1%
100x penicillin/streptomycin, 0.07% and 25 µM 10 mM
Cytosine β-D-arabinofuranoside). On the 4th day, the
medium places in each well were replaced with feeding
neurobasal medium (neurobasal medium, 2% B-27 ™
supplement (50X), 1% 200 mM L-glutamine, 1% 100x
penicillin/streptomycin, 0.07%) with a rate of 90%. Later,
the medium was changed with feeding neurobasal medium
every 3 or 4 days for 8 days until the neurons matured.

antibody (mouse monoclonal anti-MAP2) at 1:2000
concentration. The cells were then incubated with the
secondary antibody (goat anti-mouse IgG-TR) for 1 h at
room temperature. Counterstaining was done by using
4′,6-diamidino-2-phenylindole (DAPI).
2.5. Concentration trials
Concentration trials were performed to determine the
working concentration and possible toxic effects of A-T,
A-T3, and Dimethyl sulfoxide (DMSO) and the lethal
effects of Aβ on neurons. DMSO was used as a solvent for
A-T, A-T3, and Aβ. We determined the concentrations as
50 μM, 100 μM, and 200 μM for A-T and 5 μM, 10 μM, and
20 μM for A-T3, then applied the solutions to the cells for
24 h (Osakada et al., 2004; Then et al., 2009). DMSO was
used at 0.1%, and Aβ at 2 μM concentration (Yang et al.,
2010; Stine et al., 2011).
2.6. Establishment of two-dimensional in vitro
neuroprotection model
To investigate and compare the neuroprotective effects
of A-T and A-T3 derivatives of vitamin E against the
Aβ-induced neurodegeneration, we formed an in vitro
neurodegeneration model. In this context, neurons were
treated with previously tried and physiologically applicable
concentrations of A-T and A-T3 for 24 or 48 h before Aβ
was applied (Osakada et al., 2004; Then et al., 2009.).
Then, 2 μM of Aβ was applied for 24 h. In brief, before
Aβ administration, neurons were treated with 100 μM A-T
and 10 μM A-T3 for 48 and 72 h (Figure 1).
After this process, cell viability, cytotoxicity, apoptosis,
necrosis, amount of Aβ accumulation, and expressions
of BACE1 and Cacna1c were measured with established
methods.

2.4. Primary cortical neuron characterization
Immunocytochemical staining was performed using the
anti-MAP2 antibody targeting the neurons’ cytoskeleton
to characterize the neurons obtained with primary culture.
Neurobasal medium was removed, and mature neurons
were washed with phosphate buffer saline (PBS) and fixed
with –20 °C methanol for 5 min at room temperature.
Subsequently, the permeability of the cells was achieved
with 0.1% Triton X-100 for 3 min at room temperature.
After blocking was performed with the blocking solution,
the cells were incubated at 4 °C overnight with the primary

a)Primary isolated neurons
are seeded in
96-well culture dish.

®
►

After neurons have matured, incubate for
24 hours with 100 µM A-T or 10 µtM A-T3.

b) Primary isolated neurons
are seeded in
96-well culture dish.

®
►

After neurons have matured, incubate for
48 hours with 100 µM A-T or 10 µtM A-T3.

Neurons are incubated with
2 µM Ap for an additional 24 hours.

Analyses

------------� Analyses
Neurons are incubated with
2 µM Ap for an additional 24 hours.

Figure 1. Overview of the experimental setup. Primarily isolated neurons were seeded in 96-well plates. After they matured, A-T and
A-T3 were applied for 24 (a) or 48 (b) h. Then, cells were incubated with Aβ for additional 24 h without removing A-T and A-T3. The
established experimental groups were analyzed at the end of the incubation process.
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2.7. Examination of cell viability and cytotoxicity
The MTT assay is a standardized colorimetric cell viability
assay that determines the ability of the living cells to form
MTT formazan crystals with succinate dehydrogenase
enzyme activity (Durukan et al., 2019). For performing the
MTT assay, the culture medium on neurons was removed,
and cells were rinsed with PBS. Serum-free medium
containing 10% MTT solution was added on top of the
cells and incubated for 4 h at 37 °C, with 5% CO2. Then,
the MTT solution was removed, and isopropanol was
added to solve the formazan crystals and obtain a violetlike color. The absorbance values were measured at 570 nm
wavelength via the ELISA microplate reader (μQuantTM,
BiotekW Instruments Inc, USA). We have obtained the
ratio of cell viability by calculating the percentages of the
experimental groups compared to the positive control
(Equation 1).					
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉 (%) =

𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴
𝑥𝑥100
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴

(Equation 1)
The neutral red assay is an assay that uses the ability to
incorporate and bind the neutral red dye into lysosomes of
living cells. This cytotoxicity test, used in many biomedical
applications, enables quantitative analysis of the number
of live cells and cytotoxicity in cell culture (Repetto et al.,
2008). For the neutral red assay, the culture medium on
the cells was removed, and the cells were rinsed with PBS.
Then, the serum-free medium containing 10% neutral red
was applied to the cells at 37 °C for 3 h. After incubation,
the neutral red medium was removed, and the cells were
washed with PBS. The fixation was performed with a
solution containing 0.1% CaCl2 and 0.5% formaldehyde.
After fixation, we added a solution containing 1% acetic
acid and 50% ethanol, and the cells and cells were incubated
at 37 °C for 10 min to extract the dye. After the incubation,
the absorbance values of
 the samples were measured
on the ELISA microplate reader (μQuantTM, BiotekW
Instruments Inc, USA) at 490 nm. The cytotoxicity

ratio was obtained by calculating the percentages of the
experimental groups compared to the positive control
(Equation 2).					
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 − 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴

Cytotoxicity (%) =
𝑥𝑥100
						
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴

(Equation 2)
2.8. Demonstration of Aβ accumulation with Congo red
dye
We used Congo red dye to show the Aβ accumulation in
the groups treated with 2 μM Aβ. Media from cells treated
with Aβ was removed. After washing with PBS, cells
were fixed with cold 100% methanol for 5 min at room
temperature. After fixation, nucleus staining was done

with hematoxylin. Then, 0.1% Congo red solution was
applied to the cells. After staining was finished, Congo red
residues were removed by washing with PBS, and stained
Aβ fragments were observed with invert-fluorescence
microscopy (Olympus IX70 Inverted Microscope, Japan).
Then, the percentage of areas stained with Congo red dye
was measured using Image J (National Institutes of Health,
USA).
2.9. Acridine orange/propidium iodide staining
AO and PI are fluorochromes bound to DNA and emit
green and orange fluorescence. While AO crosses the
membrane of living and early apoptotic cells and causes the
green nuclei and intact structure or bright green nucleus,
respectively, PI causes an orange nucleus on late apoptotic
and necrotic cells (Abdel Wahab et al., 2009). Neurobasal
medium was removed from cells, and the cells were rinsed
with PBS. Then they were stained with the 1:1 mixture of
AO:PI for 1 min. Dye was removed from the cells, and cells
were rinsed twice with PBS. Then, imaging was performed
with inverted microscopy (Olympus IX70 Fluorescence
Microscope, Japan), and apoptotic and necrotic cells were
counted via Image J (National Institutes of Health, USA).
We have performed counting following the previous
studies. We counted:
-Uniform green cells with organized structure as living
cells,
-Cells with bright green areas of chromatin condensation
as early apoptotic cells,
-Cells that have dense orange chromatin condensation as
late apoptotic cells,
-Cells that are orange and have intact nuclei as necrotic
cells.
We examined three different images to count the cells
for each group, and apoptotic and necrotic cells were
calculated via Equations 3 and 4 (Ciapetti et al., 2002;
Abdel Wahab et al., 2009).
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 (𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑜𝑜𝑜𝑜 𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙)
						
Apoptotic Cells (%) =
𝑥𝑥100

(Equation 3)

Necrotic Cells (%) =

𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐

𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝑥𝑥100
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐

(Equation 4)
2.10. Real-time polymerase chain reaction analysis
To examine the protective effects of A-T and A-T3 against
Aβ-induced neurodegeneration at the molecular level,
CACNA1c, which controls calcium channels, and BACE1,
which is related to the metabolism of APP protein, were
selected (Bhat et al., 2012; Das and Yan, 2017).
Primers of about 20 bases were explicitly designed for
CACNA1c and BACE1 genes using the Primer3 version
V4.0 (Howard Hughes Medical Institute, USA) program

391

ÖZDEMİR et al. / Turk J Biol
and purified by the desalting method. To prevent DNA
contamination, disposable columns and pipette tips were
used, and sterile laboratory environment conditions were
provided. The primers were designed according to the
cDNA sequences. Cells were analyzed for the CACNA1c
and BACE1 gene expressions using the designed primers.
The sequences of the primers used in the study are given in
Table 1. The design and synthesis steps of the primers were
carried out by BMLabosis BM Lab. Sist. Ltd. Şti. (Ankara,
Turkey).
In order to perform real-time polymerase chain reaction
analysis (RT-PCR), RNA was isolated from the cells, the
isolated RNAs were converted into complementary DNA
(cDNA), and the expression levels of the relevant gene
regions were examined by RT-PCR analysis.
RNA was isolated from cells using the TRI reagent
protocol. In this context, neurons were collected by using
TRI Reagent. Then 0.2 mL of chloroform was added for
every 1 mL of TRI reagent used for forming a three-phase
formation in the tubes. Since the RNA content is present
in the uppermost colorless aqueous phase, this phase
was separated, and 0.5 mL of isopropanol was added
for every 1 mL of TRI reagent used to isolate the RNA
purely. After incubation at room temperature, the samples
were centrifuged at 2–8 °C for 10 min at 12,000 RCF.
Ethanol (75%) was on the samples, and the samples were
centrifuged. The supernatant was removed for the RNA to
dry. After drying, the samples were diluted with 250 μL
nuclease-free water.
The total RNA concentration was calculated with
a NanoDrop device (NanoDrop Q 5000 UV-Vis
spectrophotometer, Quawell Technologies Inc, China).
Conforming to the manufacturer’s protocol, a sufficient
amount of RNA was used to synthesize cDNA with a
Transcriptor High Fidelity cDNA Synthesis Kit (Roche
Molecular Systems, Inc, USA), and RT-qPCR was
performed with a LightCycler® 480 SYBR® Green I Master
(Roche Molecular Systems, Inc, USA). The glyceraldehyde
3-phosphate dehydrogenase (GAPDH) gene was used as
an internal control for relative expression analysis.

2.11. Statistical analysis
All results were evaluated statistically with GraphPad
Prism version 5.0 (GraphPad Software Inc., San Diego,
CA, USA) and represented as the mean ± standard
deviation (SD). We compared the statistical significance
levels between different groups such as control, Aβ, A-T +
Aβ, and A-T3 + Aβ with the one-way analysis of variance
(ANOVA) post-test of Tukey’s multiple comparison test,
and p-values less than 0.05 were considered statistically
significant.
3. Results
3.1. Primary neuron isolation, culturing, and
characterization
Neurons isolated from 17–18-day-old rat embryos were
incubated in feeding neurobasal medium. After 8 days,
increased cell size and development of long and distinct
neurites were observed. In these neurons, rounded cell
bodies were decreased and changed to the neuronlike
morphology. At this point, they were considered mature
(Figures 2a and 2b). No passaging process has been carried
out on the neurons.
After the neurons matured, they were characterized
using anti-MAP2 antibody via fluorescence staining
method before the experimental stage. We showed that
this neuron culture was almost pure neuronal culture
(Figure 2c).
3.2. Measuring cell viability and cytotoxicity
In concentration trials, it was revealed that the determined
doses of DMSO, A-T, and A-T3 did not have a significant
toxic effect on neurons, and the 2 μM Aβ significantly
decreased the cell viability on 24 h of application. After
24 h of Aβ administration, cell viability was significantly
decreased to 56% (p ≤ 0.001), and cytotoxicity was
observed on 65% (Figure 3).
A statistically significant decrease was not observed
in the A-T-treated group for 48 h in cell viability, and it
was observed at 95% at the end of the 48 h of application.
However, at this time section in the A-T3-treated group,
cell viability was decreased by 81%. In the groups treated
with both Aβ and one of the vitamin E derivatives, the

Table 1. Primer sequences of target genes.
Target gene
CACNA1c
BACE1
GAPDH
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Primer
Primer sequence (5’ – 3’)
type
Forward CTCCAGTTGCCTGTCTGAGG
Reverse

Scale of
Number TM GC
synthesis (nmol) of bases (°C) (%)
50
20
61
60

GCTCCCATAGTTGGAACCTCC 50

21

62

57

MW
NCBI
nmol
(g/mol)
Accession “
6100
59
204
6342
76

Forward ATGGCTTTTGGCTAGGGGAG

50

20

59

55

6244

66

Reverse TGGCCGTAGGTATTGCTGAG
Forward TTGTGCAGTGCCAGCCTC
Reverse ATGAAGGGGTCGTTGATGGC

50
50
50

20
18
20

59
58
59

55
61
55

6204
5467
6253

77
64
59

201
202
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Figure 2. 0-day (a), 8-day (b), and immunolabeled (c) images of neurons. Neurites are shown with the arrow (↑) sign. Immunolabeled
images were captured at 20× magnification, while other images were captured at 10× magnification. Immunolabeled images of neurons
obtained from the primary isolated neurons were labeled with anti-MAP2 antibody. Primary antibody: mouse monoclonal Anti-MAP2
(1: 2000 concentration), secondary antibody: goat antimouse IgG-TR (1: 100 concentration), cell nuclei: blue (Marked with DAPI),
somas and axons: red.
Concentration Trials
120

100

80

60

***

40

20

Control

50uL-A-T

100uL-A-T

200uL-A-T

5uLA-T3

I0uLA-T3

20uL A-T3

DMSO

Figure 3. The concentration trials of Aβ, DMSO, and three different doses of
A-T and A-T3; all groups were compared statistically against the control group;
Vitamin E derivatives and DMSO did not cause any adverse effects on cell viability. Cell viability was measured significantly lower in the Aβ application
group (***: p ≤ 0.001)

cell viability was significantly increased, and the rate
of cytotoxicity was observed to be significantly lower
compared to the group treated with only Aβ. Cell viability
exceeded 70% in these groups, and cytotoxicity was
observed below 10%. Comparing the A-T and A-T3’s
protective effects, cell viability was significantly increased
to 79% in the A-T + Aβ group (p = 0.00290) and 73% in
the A-T3 + Aβ group (p = 0.03043) when compared with
the group that treated with only Aβ. Cytotoxicity values
were observed as 4% in the A-T + Aβ group and 10% in the
A-T3 + Aβ group, and the p-values were measured below
0.001. No statistically significant difference was observed
between these two groups in terms of percent cell viability
and percent cytotoxicity values (Figures 4a and 4b).
Cell viability did not significantly decrease in 72
h of application of A-T, and it was observed at 92%.
Nevertheless, cell viability was slightly reduced in the

A-T3 treatment group, and it was at 81% again. Derivatives
of vitamin E never reduced cell viability below 70% in
any experimental groups. In the groups treated with
both Aβ and vitamin E derivatives, the cell viability was
significantly higher than those treated with only Aβ, and
p-values in these groups were always measured to be below
0.001. The rate of cytotoxicity also decreased significantly
compared to the Aβ applied group. While cell viability was
82% in the A-T + Aβ group, it was 88% in the A-T3 + Aβ
group. It was 17% in the A-T + Aβ group in cytotoxicity
and 6% in the A-T3 + Aβ group. There was no statistically
significant difference between these two groups regarding
cell viability and cytotoxicity values (Figures 4c and 4d).
3.3. Comparing the amounts of Aβ accumulation
Congo red staining was performed to observe the Aβ
accumulation. The regions stained with Congo red were
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Figure 4. The cytotoxicity and viability values of neurons after the neuroprotection model have been
established (a, b, c, d). Cell viability decreased significantly with the Aβ application. Cell viability was
significantly higher in the groups in which vitamin E derivatives and Aβ were applied together than
in the group in which Aβ was applied alone. a) Cell viability % values of 48-h application groups, b)
cytotoxicity % values of 48-h application groups, c) cell viability % values of 72-h application groups,
d) cytotoxicity % values of 72-h application groups (*:p ≤ 0.05, **:p ≤ 0.01, ***: p ≤ 0.001), control:
group with nothing applied, A-T: 100 μM of A-T-treated group, A-T3: 10 μM of A-T3-treated group,
Aβ: 2 μM of Aβ-treated group, A-T+Aβ: 48 or 72 h A-T- and 24 h Aβ-treated group, A-T3+Aβ: 48 or
72 h A-T3- and 24 h Aβ-treated group.

analyzed using Image J (National Institutes of Health,
USA). In the group treated with only 2 μM Aβ, Aβ plaques
accumulated in 30% of the area marked with Congo
red. This accumulation showed a significant decrease
with 48 and 72 h of applications of A-T and A-T3. The
amount of Aβ accumulation was analyzed as 10% in 48
h of application of A-T (p = 0.00152) and 14% in A-T3
(p = 0.00304). In the 72-h application, the amount of Aβ
accumulation was observed as 19% in the A-T group (p
= 0.03391) and 12% in the A-T3 group (p = 0.00578). No
statistically significant difference was found between A-T
and A-T3 groups regarding percentage Aβ accumulation
in both 48 and 72 h of application (Figure 5).
3.4. Comparing the real-time polymerase chain reaction
analysis
RT-PCR results were analyzed by the delta Ct method and
normalized with the GAPDH housekeeping gene. After
normalization, the expression amounts of CACNA1c
and BACE1 genes were calculated. When the amount
of gene expression was examined, it was observed that
CACNA1c expression in neurons significantly increased
when treated with 2 μM Aβ for 24 h, and p-value was
measured at 0.00565 value. A significant decrease was
observed in Aβ + A-T (p = 0.00739) and A-T3 + Aβ (p =
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0.02095) groups in terms of CACNA1c expression at 48
h of application. The relative CACNA1c expression also
significantly decreased in the A-T + Aβ group at 72 h of
application (p = 0.014665). Besides the control group, the
lowest expression of CACNA1c was observed in the A-T3
+ Aβ group (p = 0.00593) at 72 h of application (Figure
6b). Even though different amounts of expressions have
occurred between Aβ + A-T and A-T3 + Aβ groups in
different periods, there was no statistically significant
difference between these groups. Even if an increase in
the amount of the BACE1 gene was observed after 2 μM
Aβ administration for 24 h (p = 0.060754), this increase
was not statistically significant. With the A-T and A-T3
applications, the increased expression levels of BACE1
were decreased (Figure 6b).
3.5. Apoptotic and necrotic cell staining
Apoptosis and necrosis percentages were examined using
Image J (National Institutes of Health, USA). It was found
that necrosis was not observed in neurons in the control
group. In addition, only a meager percentage of early
apoptosis (11%) and late apoptosis (2%) were observed in
these groups. There was an increase in late apoptosis and
necrosis percentages in the group where Aβ was applied.
As a result of the analysis, 63% of the total cell percentage
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Figure 5. Congo red staining of Aβ accumulation in the neuron culture and comparison
of Aβ accumulation in Aβ, A-T + Aβ, and A-T3 + Aβ groups. More than 25% of the total
area is marked with Congo red in photographs taken in the Aβ application group. In the
A-T+Aβ and A-T3+Aβ groups, the marked area was observed below 15%. Arrow (↑)
sign was used to show Aβ accumulations. a) Comparison of Aβ accumulation amounts in
48-h groups, b) comparison of Aβ accumulation amounts in 72-h groups, c) Congo red
staining of the group without Aβ application, d) Congo red staining of the group with Aβ
application. (All groups compared statistically against the Aβ group, *: p ≤ 0.05, **: p ≤
0.01, ***: p ≤ 0.001).
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Figure 6. Relative CACNA1c and BACE1 mRNA expression levels relative to GAPDH control expression. CACNA1c expression and
BACE1 expression increased with Aβ administration. In the groups in which vitamin E derivatives and Aβ were applied together, the
expression amounts of CACNA1c and BACE1 genes were lower than those in the group in which only Aβ was applied. a) Relative expression of CACNA1c, b) relative expression of BACE1, (*: p ≤ 0.05, **: p ≤ 0.01), Aβ: 2 μM of Aβ-treated group, A-T+Aβ: 48 or 72-h
A-T- and 24-h Aβ-treated group, A-T3+Aβ: 48 for 72 h A-T3- and 24-h Aβ-treated group.

was observed as necrotic, 11% as early apoptotic, and 19%
as late apoptotic cells after 2 μM of Aβ application for 24
h. For the groups treated for 48 h, when A-T and Aβ were
applied together, the percentage of cells showing apoptosis
and necrosis was calculated as 28% and 4%, respectively.
In the A-T3 + Aβ group, the amount of apoptosis is 17%,

while the amount of necrosis is 22%. In the groups treated
for 72 h, 16% apoptotic cells and 19% necrotic cells were
observed in the A-T + Aβ group, while the percentage of
apoptotic cells did not change in the A-T3 + Aβ group,
and the percentage of necrotic cells was calculated as 10%
(Table 2).
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Table 2. Apoptosis % and necrosis % rates calculated by AO/PI
staining at 48 and 72 h of applications.
Group
Control

Aβ

A-T + Aβ

A-T3 + Aβ

Apoptosis and necrosis (%)

48 h

72 h

Early apoptosis

11.32

11.40

Late apoptosis

2.83

2.85

Necrosis

0

0

Early apoptosis

11.54

11.37

Late apoptosis

19.23

19.48

Necrosis

63.46

63.46

Early apoptosis

19.44

13.76

Late apoptosis

9.26

3.67

Necrosis

3.70

19.27

Early apoptosis

9.29

9.17

Late apoptosis

7.14

8.33

Necrosis

22.86

10.83

4. Discussion
Neurodegeneration can be defined as the loss of structure
and function of neurons. Aβ, a protein fragment, is
the most common cause of Alzheimer’s disease and
neurodegeneration. Although Aβ causes a toxic effect on
neurons, studies show that antioxidants such as vitamin E
could lower these harmful effects (Sen et al., 2006; Chang
et al., 2018; Gugliandolo et al., 2019). The antioxidant
effects of vitamin E come from its radical scavenging
feature. In addition to its antioxidant properties, vitamin
E is an essential nutrient for the brain. Studies have shown
that due to vitamin E deficiency, antioxidant protection
was not sufficient to prevent neurodegeneration.
Vitamin E, as well as other biochemical factors, exerts
therapeutic or protective effects against Aβ-induced
neurodegeneration by reducing neurons’ oxidative stress
(Ulatowski and Manor, 2015; Gugliandolo et al., 2017).
Yatin et al. (2000) showed that pretreatment of 50 μM
A-T prevents Aβ accumulation and ROS formation on
hippocampal neurons. It was also revealed that decreased
plasma vitamin E levels are related to the future threat of
developing neurodegenerative diseases such as Alzheimer’s
(Yatin et al., 2000). Parallel to previous studies, we also
showed that A-T and A-T3 were protective against Aβinduced neurodegeneration. Additionally, the protective
effects of A-T3 against neurodegeneration might be higher
than A-T in more extended application periods.
Vitamin E prevents Aβ from accumulating in the
intercellular region to form plaques and the emergence
of Aβ-induced abnormalities (Mazur-Kolecka et al.,
2006). Ibrahim et al. (2021) showed that both A-T and
A-T3 affected the Aβ aggregation. While A-T reduces the
Aβ aggregation in high concentrations, A-T3 can reduce
it in much lower concentrations (Ibrahim et al., 2021).
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However, in another study, it has been shown that the
usage of vitamin E at higher concentrations may cause a
decrease in cell viability and increase cytotoxicity. When
A-T was applied at 200 μM and above concentration, cell
viability in neurons decreased by 40%, and cytotoxicity
increased above 20% (Then et al., 2009). In the light of
these studies and our concentration trials, we decided to
use A-T and A-T3 at 100 μM and 10 μM concentrations,
respectively. A significant decrease in the amount of Aβinduced cytotoxicity and necrosis was observed with the
application of A-T and A-T3. Some studies show that
A-T or A-T3 applications can reduce the amount of Aβ
accumulation (Yang et al., 2010; Gugliandolo et al., 2019;
Ibrahim et al., 2021). Parallel with these studies, we also
measured the amount of Aβ accumulation as significantly
lower in the A-T and A-T3 application groups. This
informs us that the A-T and A-T3 isoforms of vitamin E
show their protective effects on neurons by reducing the
amount of Aβ accumulation and reducing cytotoxicity.
We also showed that A-T and A-T3 protect cells from the
unprogrammed form of cell death, necrosis, by preventing
Aβ-induced stress. When these results and previous studies
in the literature are evaluated together, it can be concluded
that A-T and A-T3 act as protective agents against Aβinduced stress. Our results also suggest that A-T3 can act
at lower concentrations against Aβ accumulation, thus
making it a better protective agent than A-T. Besides, A-T
and A-T3 also showed a regulatory effect on CACNA1c
and BACE1 genes.
We found that treatment with A-T and A-T3 prior to
Aβ administration has a statistically significant reducing
effect on increased CACNA1c expression on neurons. As
described by Sciacca et al. (2018) and Berridge (2010),
defects in the intracellular mechanisms that regulate
calcium channel influx that normally regulates neuron
functioning cause deterioration in neurons. Studies
show that Aβ accumulation can disrupt the calcium
signaling pathway and affect the calcium balance in the
cell. Previous studies show that vitamin E may influence
the mechanisms that regulate the calcium channel influx
of neurons besides its antioxidant effects (Berridge, 2010;
Bhat et al., 2012 Sciacca et al., 2018). Similarly, the A-T and
A-T3 applications reduced the CACNA1c expressions of
the neurons by 50%–75% compared with the Aβ treatment
group. This suggests that the A-T and A-T3 can prevent the
expression of calcium channels and keep neurons’ calcium
levels at homeostasis. Vitamin E also reduces the BACE1
expression by reducing the amount of cholesterol (Grimm
et al., 2016; Das and Yan, 2017). Parallel with these studies;
we also measured a decrease in the expression of the
BACE1 gene. However, our results for BACE1 expression
were not statistically significant.
A-T, the most basic form of vitamin E, protects
neurons against Aβ-induced neurodegeneration (Yatin et
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al., 2000; Sung et al., 2004; Lloret et al., 2019). However,
according to other studies, A-T3 could be more effective
against neurodegeneration than A-T. It shows more
neuroprotective effects in nanomolar concentrations
than A-T. In addition, the A-T3-rich fraction isolated
from palm oil reduces the Aβ oligomerization and can
be used as an alternative treatment against Aβ-induced
neurodegeneration (Khanna et al., 2006; Ibrahim et al.,
2017). It is also shown that 10 μM of A-T3 protected
neurons better against H2O2-induced cell death than the
same amount of A-T (Osakada et al., 2004). Based on these
studies, we compared A-T and A-T3 against Aβ-induced
neurodegeneration and observed different amounts of
protective effects on neurons treated with A-T and A-T3
at different periods. In 48 h of application, cell viability in
A-T + Aβ group was higher, and cytotoxicity was lower
when compared with A-T3 + Aβ group. In addition, the
amount of Aβ accumulation was observed to be lower in
this group. We also observed a difference in the percentages
of necrotic cells between the A-T + Aβ and A-T3 + Aβ
groups. As shown in Table 2, A-T3 was more successful
than A-T in protecting cells against Aβ-induced necrosis
within 72 h of application. In parallel with cytotoxicity,
amount of Aβ accumulation, and RT-PCR results, the
effect of A-T3 is less in 48 h of application compared to
72 h of application. In the A-T group, this situation is the
opposite. As claimed by a study, oxidative stress induces
necrosis by causing mitochondrial hyperpolarization
(Choi et al., 2009). Thus, in more extended application
periods, A-T3 might be decreasing the necrosis more than
A-T due to its oxidative stress inhibiting effects. It could
be interpreted that when comparing low concentrations of
A-T3 with high concentrations of A-T, it not only prevents
Aβ-induced necrosis but can also increase its protective
effect in more extended periods of application.
Grimm et al. (2016) claim that A-T and A-T3 have
similar effects on neurodegeneration in preventing ROS
formation. However, tocopherols and tocotrienol might
be inducing the amyloidogenic pathway of APP and could

increase Aβ production (Grimm et al., 2016). Despite
that, Ibrahim et al. (2021) stated in their study that both
A-T and A-T3 prevent the aggregation of Aβ. While A-T
is effective at high concentrations, A-T3 is effective at
lower and higher concentrations (Ibrahim et al., 2021).
Concerning our results, in both 48 and 72 h of application
effectiveness, A-T and A-T3 were close to each other.
They both prevented Aβ accumulation in the extracellular
region and increased the viability of neurons via regulating
apoptosis, necrosis, and gene expressions. However, at 72 h
of administration, an increase in the efficacy of A-T3 was
consistently observed in each analysis, while the efficacy
of A-T remained constant. For example, we observed that
the expression of CACNA1c and BACE1 genes decreased
more in the A-T3 group compared to A-T at this period.
However, the differences between the neuroprotective
effects of A-T and A-T3 were not statistically significant.
In conclusion, there is a difference between the
protective effects of A-T and A-T3 against Aβ-induced
neurodegeneration. Even though the measured differences
were not statistically significant, these results indicate that
the protective effects of A-T3 may increase in long-term
applications compared to A-T. In order to investigate
this situation, future studies including longer application
times of A-T3 and examining the effects of these forms of
vitamin E against the mechanism of Aβ pathology may be
conducted.
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